Prep­ping for AS­CO? In­vestor Brad Lon­car of­fers his own break­down of what to watch for

Every­body has their own spe­cial line­up of the most keen­ly an­tic­i­pat­ed events sched­uled for the up­com­ing ses­sion of AS­CO this week­end. Brad Lon­car, an in­de­pen­dent in­vestor who set up the Lon­car Can­cer Im­munother­a­py ETF $CN­CR, has been prep­ping for this all year long.

Lon­car wrote up a long list of things he’ll be watch­ing for this up­com­ing week­end. I found it in­ter­est­ing and I think you will too. His list:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.